Publications by authors named "Ishiuji Y"

Itching tends to worsen at night in patients with itchy skin diseases, such as atopic dermatitis. Unconscious scratching during sleep can exacerbate symptoms, cause sleep disturbances, or reduce quality of life. Therefore, evaluating nocturnal scratching behaviour is important for better patient care.

View Article and Find Full Text PDF
Article Synopsis
  • Prurigo chronica multiformis is a specific type of skin condition primarily recognized in Japan, especially among elderly patients, characterized by extremely itchy, swollen patches on the skin.
  • The lesions evolve from small, itchy bumps to more solid nodules that might group together, often appearing on areas like the lower abdomen and lower back.
  • There is a need for more research on its incidence, variations based on geography, and how it relates to other skin diseases, and dermatologists should be informed about its unique clinical features.
View Article and Find Full Text PDF
Article Synopsis
  • Atopic dermatitis (AD) is a chronic skin disease characterized by intense itching, and new treatments like dupilumab have been developed but predicting the right treatment for each patient is challenging.
  • A study involving 110 AD patients aimed to identify factors and biomarkers that could indicate how well patients might respond to dupilumab, using various scales for assessment.
  • Findings showed that higher baseline serum LDH levels and certain comorbidities, like food allergies, were linked to poorer treatment outcomes, suggesting these could help guide treatment decisions for AD patients.
View Article and Find Full Text PDF

Itch is a protective/defensive function with divalent motivational drives. Itch itself elicits an unpleasant experience, which triggers the urge to scratch, relieving the itchiness. Still, it can also result in dissatisfaction when the scratch is too intense and painful or unsatisfactory due to insufficient scratch effect.

View Article and Find Full Text PDF

Background: Itch is the most troublesome symptom of atopic dermatitis, and it is important to assess it appropriately for optimal treatment. We discussed issues regarding itch and the most appropriate methods of assessment at the Atopic Itch Consensus Meeting (AICOM), attended by physicians and researchers with expertise in itch treatment and research.

Methods: The AICOM participants prepared a draft consensus statement that addressed the most appropriate itch assessment methods for age groups <2 years, 2-6 years, 7-14 years, and ≥15 years.

View Article and Find Full Text PDF

Background: The Recap of atopic eczema (RECAP), a new core outcome of the atopic dermatitis trial, was translated into Japanese and linguistically validated.

Methods: Translation into Japanese was accomplished according to the ISPOR (International Society for Pharmacoeconomics and Outcome Research) guidelines and the basic guidelines for scale translation. The translation process included two forward translations, reconciliation with native English speakers, third-party back translation, cognitive debriefing, review and harmonization by the original authors.

View Article and Find Full Text PDF
Article Synopsis
  • Atopic dermatitis (AD) is a chronic skin condition linked to itchiness, largely influenced by type 2 inflammatory cytokines like interleukin (IL)-4, IL-13, and IL-31, which activate sensory nerve endings to cause itching.
  • The study aimed to explore how Oncostatin M (OSM), another inflammatory cytokine found at high levels in AD skin lesions, contributes to the disease's symptoms by affecting cytokine interactions.
  • Results showed that OSM is overexpressed in AD lesions, interacts with immune cells to influence other cytokine expression, and can suppress itch responses in mice, indicating its potential role in regulating the severity of itching associated with atopic dermatitis.
View Article and Find Full Text PDF
Article Synopsis
  • * Researchers evaluated objective (Eczema Area and Severity Index - EASI) and subjective (Patient-Oriented Eczema Measure - POEM and pruritis-NRS) symptoms of AD and found strong associations between various biomarkers and these assessments.
  • * Key findings suggest that CCL26/eotaxin-3 and SCCA2 are the most effective biomarkers for measuring AD severity via EASI, while lactate dehydrogenase is best for assessing symptoms on POEM and pruritis-NRS. *
View Article and Find Full Text PDF

Atopic dermatitis itch may cause sleep disturbance and impair quality of life. For patients finding topical therapy difficult to continue, it is important to control itch and reduce scratching. This study developed algorithms to measure nocturnal sleep and scratch, using an actigraph device worn on the back of the hand, and assessed smartphone application feedback to improve adherence with therapy.

View Article and Find Full Text PDF

The aim of this study is to elucidate the relationship between 2 different types of severity-indicating parameters (i.e. between subjective and objective severity-indicating parametersin patients with atopic dermatitis.

View Article and Find Full Text PDF

Background: Hypotrichosis with juvenile macular dystrophy (HJMD) is a rare autosomal recessive inherited disorder caused by biallelic variants in the CDH3 gene encoding P-cadherin. Here, we report two Japanese sibling patients with HJMD.

Methods: Whole-exome sequencing (WES) was performed to identify disease-causing variants.

View Article and Find Full Text PDF

In the present study, we demonstrated that there is a direct relationship between scratching behaviors induced by itch and functional changes in the brain reward system. Using a conditional place preference test, the rewarding effect was clearly evoked by scratching under both acute and chronic itch stimuli. The induction of ΔFosB, a member of the Fos family of transcription factors, was observed in dopamine transporter (DAT)-positive dopamine neurons in the ventral tegmental area (VTA) of mice suffering from a chronic itch sensation.

View Article and Find Full Text PDF

Introduction: Atopic dermatitis (AD) is a chronic, relapsing, inflammatory skin disease characterized by eczema and pruritus, and frequently impairs sleep quality. Although cyclosporine improves symptoms of AD, objective evaluation of sleep in patients with AD treated with cyclosporine has not been reported. This study was conducted to elucidate the effects of cyclosporine on sleep quality for patients with AD.

View Article and Find Full Text PDF
Article Synopsis
  • Atopic dermatitis (AD) is a common skin disorder causing intense itching, and dupilumab, an anti-IL-4 receptor antibody, has shown significant success in improving symptoms and reducing inflammation associated with this condition.
  • * In a study involving over 130 patients with moderate-to-severe AD, researchers will assess clinical symptoms and measure 18 blood biomarkers to find potential predictors for treatment outcomes with dupilumab.
  • * The main goal is to explore if initial levels of these biomarkers are linked to changes in skin severity scores after 16 weeks of treatment.
View Article and Find Full Text PDF

Itch is a multidimensional experience involving various brain regions associated with sensory perception and emotion, as well as an urge to scratch employing the motor system. Scratch temporarily relieves itch sensation in healthy subjects. However, in patients with chronic itch, rather than inhibit, scratch may aggravate itch.

View Article and Find Full Text PDF
Article Synopsis
  • Chronic intestinal pseudo-obstruction (CIPO) and pneumatosis cystoides intestinalis (PCI) are rare digestive disorders often associated with systemic sclerosis (SSc), a collagen disease causing skin and organ changes.
  • A 68-year-old woman with well-managed SSc presented with abdominal fullness; imaging revealed PCI and CIPO, prompting a peristalsis evaluation via cine MRI.
  • Treatment with oral medications improved the patient's condition significantly, demonstrating that SSc can lead to both CIPO and PCI, and cine MRI is effective for assessing intestinal movement without needing surgery.
View Article and Find Full Text PDF

Background: Lipocalin-2 (LCN2), a protein secreted mainly by activated neutrophils, has been associated with neurodegeneration, obesity, and inflammatory responses. Serum LCN2 concentration has been reported elevated in patients with psoriasis, but lower in patients with atopic dermatitis (AD). Spinal astrocyte-derived LCN2 was found to be involved in enhancement of itch in a mouse model of AD.

View Article and Find Full Text PDF

The T-cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain (TIGIT) is a co-inhibitory receptor mainly expressed on T cells. Although TIGIT plays an important role in various autoimmune diseases, its role in atopic dermatitis (AD) remains unclear. In this study, we examined the expression levels of TIGIT and their association with clinical features in patients with AD.

View Article and Find Full Text PDF